JP Stock MarketDetailed Quotes

6080 M&A Capital Partners

Watchlist

2657
-21-0.78%

20min DelayMarket Closed Dec 30 15:30 JST

84.38BMarket Cap19.16P/E (Static)

M&A Capital Partners Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

M&A Capital Partners Q4 2024 Earnings Date

Currency：JPYOct 31, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	6.31B	7.65B	+1.34B
Beat Est.	+29.80%	+57.32%	+21.20%
EPS	--	79.72	--
		+150.61%

Analyst Rating

Strong Buy

Dec 17, 2024

M&A Capital Partners Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 5.521B	--
--	2025/Q1	-- / 4.160B	--
Oct 31, 2024	2024/Q4	7.650B / 6.312B	--
Jul 30, 2024	2024/Q3	4.269B / 5.780B	--
--	2024/Q2	4.091B / 4.708B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 5.521B--

--2025/Q1-- / 4.160B--

Oct 31, 20242024/Q47.650B / 6.312B--

Jul 30, 20242024/Q34.269B / 5.780B--

--2024/Q24.091B / 4.708B--

Unlock Free Earnings Estimates

Open Account

M&A Capital Partners Earnings Reports

M&A Capital Partners: Extraordinary Report

Dec 23, 2024 14:31

M&A Capital Partners: Confirmation

Dec 23, 2024 14:31

M&A Capital Partners: Financial Report - 19th Term (2023/10/01 - 2024/09/30)

Dec 23, 2024 14:30

M&A Capital Partners: Extraordinary Report

Nov 15, 2024 14:30

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 17, 2024

Strong Buy

Strong Buy
66.67%
Buy
33.33%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data